About Pureos Bioventures
Pureos Bioventures is a Financial Services company based in Pfäffikon, Switzerland. Venture capital is invested in innovative drug development companies. It operates on a Venture Capital model. Pureos Bioventures offers products and services including Venture Capital Investment. Its focus areas include Finance, Venture Capital and Biotechnology Investments.
Company details
Venture capital is invested by Pureos Bioventures in private innovative drug development companies, with a focus on next-generation biological drugs and drug formats. The portfolio includes companies operating in sectors such as oncology, fibrosis, heart failure, and neurological disorders. Solutions are advanced for severe diseases through backing great teams with impactful development programs.
- Headquarters Pfäffikon, Switzerland
- SectorsFinancial Services
- Website pureosbio.com
- Social LinkedIn
Products & Services of Pureos Bioventures
Pureos Bioventures offers a comprehensive portfolio of products and services, including Venture Capital Investment.
Venture capital is provided for innovative drug development.
People of Pureos Bioventures
26 people are tracked at Pureos Bioventures (9 in leadership, 13 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Dominik Escher | Managing Partner | Leadership |
Klaus Breiner | Managing Partner | Leadership |
Martin Münchbach | Managing Partner | Leadership |
Dragan Grabulovski | Venture Partner | Leadership |
Lars Nieba | Venture Partner | Leadership |
Christian Altorfer | CFO / COO | Leadership |
Sai Reddy | Venture Partner | Leadership |
Ulf Grawunder | Venture Partner | Leadership |
Veronica Gambillara Fonck | Partner | Leadership |
Bernd Seizinger | Advisory Board | Board & advisors |
Roger Nitsch | Advisory Board | Board & advisors |
Dallas Webb | Advisory Board | Board & advisors |
Omar Khwaja | Advisory Board | Board & advisors |
Mathieu Simon | Advisory Board | Board & advisors |
Bruno Teta | Pureos Partners Board | Board & advisors |
Matthias Staehelin | Pureos Partners Board | Board & advisors |
Jan Møller Mikkelsen | Chairman | Board & advisors |
Thomas Baumert | Advisory Board Member | Board & advisors |
Sonia Quaratino | Advisory Board Member | Board & advisors |
Ben Morgan | General Partner Board | Board & advisors |
6 more people are available in the full profile.
Complete people profiles for Pureos Bioventures
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pureos Bioventures
Complete news archive for Pureos Bioventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pureos Bioventures
Venture capital is invested by Pureos Bioventures in private innovative drug development companies, with a focus on next-generation biological drugs and drug formats. The portfolio includes companies operating in sectors such as oncology, fibrosis, heart failure, and neurological disorders. Solutions are advanced for severe diseases through backing great teams with impactful development programs.
Pureos Bioventures offers Venture Capital Investment.